CalciMedica, Inc. (CALC)
NASDAQ · Manufacturing · Pharmaceutical preparations
CALC price, last 12 months
Key stats
- Previous close
- $1.74
- Open
- $1.73
- Day range
- $1.62 – $1.77
- 52-week range
- $1.62 – $36.00
- Volume
- 41.4K
- Avg volume (20 days)
- 92.9K
- Market cap
- $11.9M
Performance
Technicals and fundamentals
About CalciMedica, Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $11.9M